Craniomaxillofacial Devices Market - By Product (MF Plate and Screw Fixation System, Cranial Flap Fixation System, CMF Distraction System, Thoracic Fixation System), By Implant Type, By Materials, By Application, By Resorbability, By End-use & Forecast, 2022-2030

Craniomaxillofacial Devices Market Size

Craniomaxillofacial Devices Market size was valued at around USD 1,365 million in 2021 and is estimated to register 9% CAGR between 2022 and 2030. The growing prevalence of facial injuries and fractures is estimated to drive the global market growth. Further, rise in the number of road accidents and traumatic events is projected to fuel the demand for craniomaxillofacial devices, especially in developing countries.
 

Craniomaxillofacial devices are majorly used in the surgical procedures of trauma injuries and reconstruction of facial and skull/cranial disorders. The different types of product or systems used in craniomaxillofacial surgical procedures include MF plate and screw fixation system, cranial flap fixation system, CMF distraction system, temporomandibular joint replacement system, thoracic fixation system and bone graft substitute systems.
 

However, high cost of craniomaxillofacial surgeries that incorporate these devices and lack of awareness in developing regions may negatively impact the adoption of craniomaxillofacial devices, thereby impacting the industry growth. Craniomaxillofacial surgery involves dealing with congenital and acquired deformities of skull that is much more complicated and difficult than other surgeries, and involves participation of neurosurgeons, plastic surgeons, etc. making the overall procedure quite expensive.
 

In addition, craniomaxillofacial devices are very costly since they must be made sterile, long-lasting, and requires extensive research & testing, thereby adding on to the overall pricing. Thus, the high cost of surgery and craniomaxillofacial devices might limit its adoption, especially in developing economies that may be a restraining factor for craniomaxillofacial devices market growth.
 

The COVID-19 pandemic emerged as a serious public health concern that distorted various country’s economy, increased strain on the healthcare system, and proliferated the disease burden. Several businesses including healthcare industry experienced incremental transitions. Hospital admissions and associated medical services were offered on priority basis to the people suffering with COVID-19 that led to ignorance towards other medical practices, notably elective medical operations. Thus, such developments had negatively impacted the market growth during 2020.
 

The coronavirus pandemic has affected oral maxillofacial surgery (OMS) practice. As per the research article published by the National Centre for Biotechnology and Information (NCBI), medical professionals had postponed many elective surgeries, including several oral non-urgent procedures. Countries with high number of COVID-19 cases witnessed a slight drop in the operation volume.
 

Maxillofacial departments in countries such as Italy, U.S., Brazil, and others were increasingly involved in facing the COVID-19 emergency and catering to clinical needs of heightened patient influx. However, various countries that were declared COVID free initiated the craniomaxillofacial surgeries.
 

In addition, according to the news articles, in 2020, several planned surgeries were postponed across the world, due to COVID-19 pandemic leading to patients experiencing a lengthy wait for their health issues to be resolved. Hence, the overall COVID pandemic negatively affected the market growth, although the craniomaxillofacial devices business is set to progress in coming years.
 

Craniomaxillofacial Devices Market Analysis

The surging prevalence of facial injuries and fractures is projected to accelerate the craniomaxillofacial devices market expansion in the coming years. Some of the most profound factors driving the incidence of facial fractures include incidents such as motor vehicle accidents, domestic accidents, work-related injuries, violence, and sports, among others. Among these, road traffic accidents account for a dominant portion of maxillofacial trauma events. Non-fatal traffic accidents drive the patient influx at healthcare facilities every year.
 

As per the Global Burden Disease 2017 Study, facial fractures accounted for approximately 7.5 million new cases and around 1.8 million prevalent cases. With respect to age-standardized incidence, prevalence, and years lived with disability (YLDs), the overall rates were 98, 23, and 2 per 100,000 individuals, respectively.
 

Such high incidence of road accidents results in nasal, mandible, and cranial bone fractures resulting in significant number of surgical procedures, thereby driving the craniomaxillofacial devices market demand. These statistics indicate high growth potential for market, with adoption of craniomaxillofacial devices to treat these fractures & injuries.
 

Facial fractures are serious injuries that can be potentially disabling injuries and mandate complex surgical care. Delayed treatment of facial fractures might have devastating consequences, further leading to permanent dysfunction in certain cases. Moreover, there is notable burden of facial injuries in developing economies that lack access to timely and effective care. Hence, these factors are projected to increase the number of people opting for craniomaxillofacial surgeries, thereby boosting the market forecasts.
 

Based on product, the market is segmented as MF plate and screw fixation system, cranial flap fixation system, CMF distraction system, temporomandibular joint replacement system, thoracic fixation system, and bone graft substitute system. MF plate and screw fixation system accounted for highest market share in 2021 and is forecast to expand at 8.9% CAGR during the estimation timeframe.
 

This majority market share is majorly due to its broad range of application in multiple surgical operations comprising deformity correction, tumour removal, orthognathic surgery, and other surgeries. Also, rise in craniomaxillofacial procedures with the increased number of accidental events & the rising demand for technologically advanced products is expected to boost the market trends in the forthcoming years.
 

Based on implant type, the market is segmented as standard implants, and customized/patient-specific implants. Standard implants segment dominated the market with more than 66% revenue share and is projected to witness substantial growth during the analysis timeframe. With growing R&D activities and innovations, companies have made significant contribution in manufacturing technologically advanced craniomaxillofacial products for standard surgical procedures. Hence, improvisation in standard implants has resulted in minimal problems associated with craniomaxillofacial devices, thereby augmenting the craniomaxillofacial devices market outlook.
 

Based on location, the craniomaxillofacial devices market is segmented as internal fixators and external fixators. Internal fixators segment is projected to reach over USD 2,294 million by 2030. A host of factors such as the developments in internal fixation technology, enhancements in plating materials & devices, and the surge in the volume of facial trauma have propelled the expansion of utilization spectrum of internal fixators for facial fractures.
 

Moreover, with growing knowledge, manufacturers-initiated research & development activities pertaining to resorbable rigid fixation systems that are being preferred in managing the facial trauma as these novel systems overcome several pitfalls and complications concerned with conventional implants. Thus, the above-mentioned factors are anticipated to drive the market expansion in near future.
 

Based on material, the craniomaxillofacial devices market is segmented as metals, bio-absorbable materials, ceramics, and polymers. Metals segment accounted for majority share with more than 58% revenue share and is set to experience notable business growth during the forecast period. Metallic implants possess the ability to impersonate the assistance and protective features of bone, with nominal effect on bone healing, remodelling, and growth.
 

These implants also aid in avoiding toxicity to associated tissues. Plating mechanisms for CMF implants are composed of cobalt-chromium alloys, stainless steel, and titanium alloys. Each metallic implant features basic biomechanical and biocompatible mandates to be acceptable clinically. Thus, clinical benefits offered by metallic craniomaxillofacial devices are anticipated to promote the market share.
 

Based on application, the craniomaxillofacial devices market is segmented as trauma reconstruction surgery, orthognathic surgery, and plastic surgery. Orthognathic surgery segment is expected to reach more than USD 1,228 million by 2030. The growing number of orthognathic surgeries with increasing prevalence of jaw deformities is set to drive the segment growth.
 

As per the Contemporary Clinical Dentistry article, in 2020, the surged number of developmental cysts recommends that variables such as eruption and exfoliation of teeth coupled with the continuous growth of jaws attributes to higher prevalence in pediatrics. The increased prevalence would drive the orthognathic application of craniomaxillofacial devices.
 

Based on resorbability, the craniomaxillofacial devices market is segmented as resorbable fixators and non-resorbable fixators. Resorbable fixators segment is projected to reach around USD 975 million by 2030. The resorbable fixators product are considered as revolutionary devices for the use in craniomaxillofacial surgeries. The resorbable meshes are heated up and moulded in shape to fit at the application site.
 

Also, the resorbable fixators are convenient, fast, easy and safe-to-use. Hence, owing to the aforementioned factors and advantages, the demand and adoption rate of resorbable fixators is projected to grow over the forthcoming years.
 

Based on device type, the craniomaxillofacial devices market is segmented as reconstruction surgery devices and trauma surgery devices. Trauma surgery devices segment held substantial share with more than 32% in 2021 and is projected to witness notable CAGR over the forecast timeframe. The increase in number of road accidents along with several bone fractures is set to proliferate the demand and adoption rate of craniomaxillofacial devices. Furthermore, surge in the traumatic events since the last two decades is anticipated to proliferate the craniomaxillofacial devices industry landscape in coming years.
 

Based on end-use, the market is segmented as hospitals, ambulatory surgical centers, and others. Hospitals segment accounted for majority revenue share in 2021 and was valued at USD 822.5 million. Most of the craniomaxillofacial surgeries are conducted in hospitals, owing to the presence of technologically advanced equipment, facilities, and skilled professionals in these healthcare settings.
 

Also, several additional provisions such as intensive care units and post-surgical support will result in more people opting for hospitals. Hence, owing to several benefits offered by these healthcare settings, hospitals segment is projected to show substantial growth over the estimation period.
 

The U.S. craniomaxillofacial devices market dominated the North American region with more than 89% revenue share in 2021 and is anticipated to reach more than USD 1,280 million by 2030. This majority share is primarily owing to multiple factors such as the high number of road traffic accidents, traumatic events injuries, and the presence of prominent players in the U.S.
 

For instance, The U.S. Department of Transportation's Fatality Analysis Reporting System (FARS), in 2020, stated that over 35,000 fatal road accidents were reported in the country. These incidents are classified as high-energy trauma events that lead to facial fractures & injuries among some of these patients. These traumatic incidents are projected to propel the adoption rate of craniomaxillofacial devices in U.S.
 

Craniomaxillofacial Devices Market Share

Some of the major players operating in the craniomaxillofacial devices industry are

• Johnson & Johnson
• Stryker Corporation
• Medtronic
• Aesculap Implants Systems (B Braun Melsungen AG)
• Zimmer Biomet

These major players emphasize adoption of strategic initiatives such as vertical integration, partnerships, mergers & acquisitions among others for industry expansion. Furthermore, these players are heavily investing in research & development activities that enables them to launch novel products and garner maximum revenue.
 

Recent industry developments:

• In April 2018, Medtronic’s Infuse Bone Graft received U.S.FDA approval. This approval enabled Medtronic to cater to oral maxillofacial surgery patients, thus broadening its customer base and helped the company to expand its product offerings, thereby driving revenue growth.
   
• In October 2017, Integra Life Sciences acquired Johnson & Johnson Codman Neurosurgery business. This acquisition helped the company to diversify its product portfolio, enhance its industrial position, and capitalize on business growth opportunities. The firm is also engaged in an innovative product launch to expand their product portfolio and extend their services to expand their customer base.
   

Craniomaxillofacial devices market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2017 to 2030, for the following segments:

Click here to Buy Section of this Report

By Product

• MF Plate and Screw Fixation System
• Cranial Flap Fixation System
• CMF Distraction System
• Temporomandibular Joint Replacement System
• Thoracic Fixation System
• Bone Graft Substitute System

By Implant Type

• Standard Implants
• Customized/Patient-specific Implants

By Location

• Internal Fixators
• External Fixators

By Materials

• Metals
• Bioabsorbable Materials
• Ceramics
• Polymers

By Application

• Trauma Reconstruction Surgery
  • Cranial Surgery
  • Mid-face Surgery
  • Mandibular Surgery
  • Orbital Floor Reconstruction Surgery
• Orthognathic Surgery
• Plastic Surgery

By Resorbability

• Resorbable Fixators
• Non- Resorbable Fixators

By Device Type

• Reconstruction Surgery Devices
• Trauma Surgery Devices

By End-use

• Hospital
• Ambulatory Surgical Centers
• Others

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Russia
  • Austria
  • Belgium
  • Czech Republic
  • Denmark
  • Estonia
  • Finland
  • Greece
  • Hungary
  • Ireland
  • Lithuania
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovenia
  • Sweden
  • Switzerland
  • Turkey
  • Ukraine
  • Croatia
  • Slovakia
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Taiwan
  • Indonesia
  • Malaysia
  • New Zealand
  • Philippines
  • Singapore
  • Thailand 
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Peru
  • Chile 
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • Kuwait
  • Israel